Page last updated: 2024-11-02

pamidronate and Retinal Pigment Epithelial Detachment

pamidronate has been researched along with Retinal Pigment Epithelial Detachment in 2 studies

Research Excerpts

ExcerptRelevanceReference
" We present here the first case of an acute retinal pigment epithelial detachment associated with pamidronate infusion in a 59-year-old patient with metastatic prostate cancer."7.75Acute retinal pigment epithelial detachment secondary to pamidronate administration. ( Alexandrescu, DT; Dasanu, CA, 2009)
" We present here the first case of an acute retinal pigment epithelial detachment associated with pamidronate infusion in a 59-year-old patient with metastatic prostate cancer."3.75Acute retinal pigment epithelial detachment secondary to pamidronate administration. ( Alexandrescu, DT; Dasanu, CA, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Munns, CF1
Fahiminiya, S1
Poudel, N1
Munteanu, MC1
Majewski, J1
Sillence, DO1
Metcalf, JP1
Biggin, A1
Glorieux, F1
Fassier, F1
Rauch, F1
Hinsdale, ME1
Dasanu, CA1
Alexandrescu, DT1

Other Studies

2 other studies available for pamidronate and Retinal Pigment Epithelial Detachment

ArticleYear
Homozygosity for frameshift mutations in XYLT2 result in a spondylo-ocular syndrome with bone fragility, cataracts, and hearing defects.
    American journal of human genetics, 2015, Jun-04, Volume: 96, Issue:6

    Topics: Base Sequence; Cataract; Craniofacial Abnormalities; Diphosphonates; Exome; Eye Diseases, Hereditary

2015
Acute retinal pigment epithelial detachment secondary to pamidronate administration.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2009, Volume: 15, Issue:2

    Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Fluorescein Angiography; Humans; I

2009